GRAIL, Inc. (GRAL) vs Sotera Health Company (SHC)
- GRAIL, Inc. GRAL 117.81 −13.03%
- Sotera Health Company SHC 17.89 −1.00%
GRAIL, Inc. and Sotera Health Company are both Diagnostics & Research companies. GRAIL, Inc. is the larger, with a market value of $6.1B against $5.2B — 1.2× the size. GRAIL, Inc. has negative trailing earnings, so its P/E is not meaningful; Sotera Health Company trades at 31.4×. GRAIL, Inc. grew revenue faster over the last twelve months: 23.1% against 8.15%. Sotera Health Company has the higher net margin (13.4% vs −237.0%) and the higher return on invested capital (9.82% vs −20.8%). Across the 17 metrics below, Sotera Health Company leads on 11 and GRAIL, Inc. on 6.
Valuation
Profitability
| Metric | GRAL | SHC | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | (31.31%) | 54.97% | 50.89% |
| Operating margin | (338.40%) | 32.82% | (8.57%) |
| Net margin | (236.95%) | 13.44% | (6.37%) |
| Free cash flow margin | (179.21%) | 9.27% | 0.00% |
| Return on equity | (16.12%) | 27.78% | (2.92%) |
| Return on assets | (14.12%) | 5.01% | (6.71%) |
| Return on invested capital | (20.79%) | 9.82% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack